Big internal update for $MEDI Ketamine One ($MEDI.N $KONEF) publicized an internal update yesterday, announcing their 2021 Annual General and Special Meeting results.
The ketamine-focused mental health treatment company had 11 shareholders represented in person or by proxy at the meeting which was held in mid-December.
Together the 11 shareholders held +18.8K (or 15.69%) of the Company’s total issued and outstanding common shares.
Some important issues voted on at the meeting:
- Setting the number of directors to 4
- Overwhelmingly the voters voted to elect all the nominees for Director positions: Henning, Raey, Inglefield, and Purdy.
- Macias Gini & O’Connell were reappointed as Auditors
- The voters authorized and approved of the restricted share unit plan
Full update here: https://ca.finance.yahoo.com/news/ketamine-one-announces-2021-agsm-161100449.html
$MEDI @ $0.38 (slightly down), MC $39.273M